Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape
Portfolio Pulse from Vandana Singh
The FDA is seeking new suppliers for methotrexate, a cancer drug in short supply since March, due to disruptions in supply from India-based manufacturer Intas Pharmaceuticals. Suppliers facing shortages include Accord Healthcare, Fresenius Kabi, Pfizer Inc, Teva Pharmaceutical Industries Ltd, and Hikma Pharmaceuticals.
June 12, 2023 | 2:16 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Hikma Pharmaceuticals is facing shortages of methotrexate, a cancer drug, due to disruptions in supply from India-based manufacturer Intas Pharmaceuticals.
Hikma Pharmaceuticals is one of the suppliers facing shortages of methotrexate, a widely used cancer drug. The shortage is due to disruptions in supply from India-based manufacturer Intas Pharmaceuticals. This could negatively impact Hikma's sales and reputation in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50
NEGATIVE IMPACT
Pfizer is facing shortages of methotrexate, a cancer drug, due to disruptions in supply from India-based manufacturer Intas Pharmaceuticals.
Pfizer is one of the suppliers facing shortages of methotrexate, a widely used cancer drug. The shortage is due to disruptions in supply from India-based manufacturer Intas Pharmaceuticals. This could negatively impact Pfizer's sales and reputation in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50
NEGATIVE IMPACT
Teva Pharmaceutical Industries is facing shortages of methotrexate, a cancer drug, due to disruptions in supply from India-based manufacturer Intas Pharmaceuticals.
Teva Pharmaceutical Industries is one of the suppliers facing shortages of methotrexate, a widely used cancer drug. The shortage is due to disruptions in supply from India-based manufacturer Intas Pharmaceuticals. This could negatively impact Teva's sales and reputation in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50